Is sepsis a risk factor for bleeding in adults with hematologic malignancies?

Documents similaires

• Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
  par: Stanworth, S, et autres
  Publié: (2015)
• Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis
  par: Simon J. Stanworth, et autres
  Publié: (2015-06-01)
• Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
  par: Stanworth, S, et autres
  Publié: (2014)
• Observational study of alternative platelet parameters to predict bleeding risk in patients with hematological malignancies (ATHENA study)
  par: Estcourt, L, et autres
  Publié: (2013)
• Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
  par: Stanworth, S, et autres
  Publié: (2014)